No Data
United Therapeutics Analyst Ratings
UBS Maintains United Therapeutics(UTHR.US) With Buy Rating, Raises Target Price to $475
United Therapeutics(UTHR.US) Officer Sells US$3.55 Million in Common Stock
$United Therapeutics(UTHR.US)$ Officer BENKOWITZ MICHAEL sold 10,000 shares of common stock on Jan 6, 2025 at an average price of $355.1517 for a total value of $3.55 million.Source: Announcement
United Therapeutics Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference
United Therapeutics Insider Sold Shares Worth $3,566,800, According to a Recent SEC Filing
United Therapeutics(UTHR.US) Officer Sells US$3.57 Million in Common Stock
$United Therapeutics(UTHR.US)$ Officer BENKOWITZ MICHAEL sold 10,000 shares of common stock on Dec 30, 2024 at an average price of $356.68 for a total value of $3.57 million.Source: Announcement